Conference Exhibitors

Glenmark is a research‐led, global pharmaceutical company, with presence across branded, generics, and OTC segments; our focus therapy areas are Respiratory, Dermatology and Oncology. We are focused on developing bioequivalent as well as innovative medicines that make a difference to the NHS and fulfil the unmet needs of patients. July 2025, PP-UK-Bun-0125

GSK are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance.
NP-GB-RS-COCO-230002 | January 2024

Intermedical is a specialist provider of cardio-respiratory diagnostic equipment. We are the exclusive UK partner for Bedfont Scientific, offering the NObreath® FeNO device and the Smokerlyzer® range. Additionally, we are the UK distributor for Ndd lung function systems and MIR spirometers.

At Kenvue, we realize the extraordinary power of everyday care. Through our iconic brands – including Aveeno®, Johnson’s®, Listerine®, Neutrogena® and Nicorette® – we put this power into the hands of approximately 1.2 billion people globally, in their daily rituals and the moments that matter most. We are 22,000 dynamic and diverse team members, passionate about insights, innovation and making an impact. We are united by an unwavering courage to see and solve everyday care needs by delivering science-backed, care-forward experiences that are endorsed by healthcare professionals. With expertise and empathy, we believe in meaningful possibilities for healthier people and a healthier planet. And we’re focused on their pursuit. As the world’s largest pure-play consumer health company by revenue, we bring a new view of everyday care to the world. Learn more at https://kenvuepro.com/en-gb/

NSHI are an independent leading health services provider who delivers improved patient outcomes in primary, secondary and remote healthcare.

Our specialist clinical services use innovative technology to support healthcare communities to drive quality improvements, and implement NHS Strategies effectively and efficiently.

NIOX Group plc is the global leader in FeNO testing, with a strong reputation for innovation and excellence in the development of medical devices for the diagnosis and management of asthma. With NIOX VERO®, healthcare professionals have a reliable and non-invasive tool to help them better diagnose and manage asthma.

Pulmonx is based in Redwood City, California, and Neuchâtel, Switzerland. The company’s commercially available portfolio includes the Zephyr® Valve. More than 100 scientific articles have been published on the clinical benefits of Zephyr Valves, including multiple meta-analyses, review articles, cost-effectiveness analyses and risk-benefit analyses. It also includes:

The Zephyr Valve:
The Zephyr Endobronchial Valve is an implantable device used to occlude all airways feeding the hyperinflated lobe of a lung that is most diseased with emphysema.

StratX® Lung Analysis Reports
A cloud-based quantitative computed tomography (CT) analysis service that provides information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the Zephyr Valve treatment.

The Chartis® Pulmonary Assessment System
A proprietary balloon catheter and console provides precise flow and pressure readings for specific lobes in the lung to assess absence of collateral ventilation.

This combination of assessment tools and therapeutics enables physicians to successfully predict outcomes and provide optimal treatment for each individual patient.

For over two decades, Rotherham Respiratory has been a leader in respiratory and long-term conditions education. We empower healthcare professionals to deliver exceptional, patient-centered care through evidence-based programs led by experienced clinicians. Our practical, clinically-relevant courses provide the knowledge and confidence needed to make a positive impact on patient outcomes.

Thornton & Ross, part of the STADA group, focuses on caring for people’s health through a broad portfolio including generics, biosimilars and non-prescription consumer healthcare products as a trusted partner supplying the NHS. STADA sells its products in more than 120 countries, employing over 12,000 people worldwide.

TidalSense is an innovative respiratory diagnostics company based in Cambridge, UK. We are now launching N-Tidal™ Diagnose - a regulated, secure class 2a medical device diagnostic solution delivered as a service. It combines state of the art hardware (N-Tidal™) with AI-powered diagnostic software to deliver COPD diagnosis at the point of care within minutes.

Leveraging a revolutionary new patented sensor technology, N-Tidal™ Diagnose performs real-time geometric analysis of CO2 breath waveforms to provide highly sensitive quantification of lung function, from relaxed breathing.

We will provide more info upon meeting approval by our medical department if that's ok